Previous Close | $33.31 |
Intrinsic Value | $127.02 |
Upside potential | +281% |
Data is not available at this time.
Centene Corporation operates as a diversified healthcare enterprise, primarily serving government-sponsored healthcare programs such as Medicaid, Medicare, and the Health Insurance Marketplace. The company generates revenue through managed care services, offering health insurance plans, pharmacy benefits management, and specialty services. Centene’s business model is anchored in its ability to administer cost-effective healthcare solutions for underserved populations, leveraging scale and integrated care delivery. As one of the largest Medicaid managed care organizations in the U.S., Centene holds a dominant position in this niche, complemented by strategic acquisitions that expand its geographic and service footprint. The company’s focus on value-based care and partnerships with providers enhances its competitive edge in a highly regulated and competitive sector. Centene’s diversified portfolio mitigates reliance on any single program, providing stability amid policy shifts. Its market leadership is reinforced by long-term government contracts and a growing emphasis on addressing social determinants of health, positioning it as a critical player in the evolving healthcare landscape.
Centene reported revenue of $163.1 billion for FY 2024, reflecting its expansive operations in government-sponsored healthcare programs. Net income stood at $3.3 billion, with diluted EPS of $6.31, indicating robust profitability. Operating cash flow was $154 million, though capital expenditures of -$644 million suggest significant reinvestment in infrastructure and technology to support growth and operational efficiency.
The company’s earnings power is underscored by its ability to maintain profitability in a low-margin industry, driven by scale and cost management. Capital efficiency is evident in its strategic investments, such as technology upgrades and acquisitions, aimed at enhancing service delivery and expanding market share. The balance between growth spending and earnings retention highlights disciplined capital allocation.
Centene’s balance sheet shows $14.1 billion in cash and equivalents against total debt of $19.4 billion, indicating manageable leverage. The company’s liquidity position supports ongoing operations and strategic initiatives, while its debt levels are typical for a capital-intensive healthcare managed care provider. Financial health appears stable, with sufficient resources to meet obligations and fund growth.
Centene’s growth is fueled by organic expansion in existing markets and acquisitions, particularly in Medicaid and Medicare Advantage. The company does not currently pay dividends, opting instead to reinvest cash flows into growth opportunities and debt reduction. This aligns with its focus on scaling operations and maintaining flexibility in a dynamic regulatory environment.
Centene’s valuation reflects its position as a leader in government-sponsored healthcare, with market expectations centered on sustained enrollment growth and margin stability. The stock’s performance is influenced by healthcare policy trends and the company’s ability to navigate regulatory changes while delivering consistent earnings.
Centene’s strategic advantages include its scale, diversified program portfolio, and expertise in managing complex healthcare systems. The outlook remains positive, supported by demographic trends favoring Medicaid expansion and the company’s ability to adapt to evolving healthcare needs. Risks include regulatory changes and competitive pressures, but Centene’s entrenched market position provides resilience.
Company filings (10-K), investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |